FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Boston Scientific Recalls ENROUTE Percutaneous Catheter Kit

Boston Scientific recalls its ENROUTE Transcarotid Neuroprotection System Plus, a single-use percutaneous catheter kit used during transcarotid artery...

latest-news-card-1
Biologics

CBER Updates Process for Formal Disputes With Sponsors

CBER updates its standard operating procedures for resolving scientific/procedural disputes between sponsors and the Center, establishing revised proc...

latest-news-card-1
Human Drugs

Scholar Rock Removes Catalent Facility from BLA to Advance Apitegromab

Scholar Rock says it has made further regulatory progress for apitegromab, its investigational treatment for spinal muscular atrophy.

latest-news-card-1
Human Drugs

Lawmakers Urge FDA to Up Scrutiny of Clinical Data From China

House Select Committee on China chairman John Moolenaar (R-MI) and Rep. Ben Cline (R-VA) are urging FDA intensify safeguards on clinical trial data ge...

latest-news-card-1
Human Drugs

FDA Issues New Guidance on Therapeutic Equivalence Evaluations

FDA issues a final guidance describing how it evaluates therapeutic equivalence among prescription drug products and assigns therapeutic equivalence c...

latest-news-card-1
Medical Devices

Early Alert on : GE HealthCare Portrait Core Monitor Software

CDRH issues an Early Alert after becoming aware that GE HealthCare sent a letter alerting affected customers of updated use instructions for Portrait ...

latest-news-card-1
Human Drugs

4 Observations in Suretec Inspection

FDA warns Gilbert, AZ-based Suretec Innovations about CGMP and drug listing violations in its manufacturing of finished drugs.

latest-news-card-1
Human Drugs

No Quality Unit Seen in Safrel Pharmaceuticals Inspection

FDA warns Dayton, NJ-based Safrel Pharmaceuticals about CGMP violations in its manufacturing of finished drugs.

latest-news-card-1
Human Drugs

FDA Issues Complete Response Letter for Xspray Pharmas Dasynoc

FDA issues a complete response letter to Xspray Pharmas NDA for Dasynoc, raising issues about a third-party manufacturer.

latest-news-card-1
Human Drugs

Ultragenyx Gene Therapy OKd for Glycogen Storage Disease

FDA grants Ultragenyx Pharmaceutical accelerated approval for its Genglycos (pariglasgene brecaparvovec-opnr) for adults and children eight years and ...